4,0
9 gen 2026
Dipendente attuale
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
Growing business segment. Merging with Abbott. Upcoming products
Svantaggi
Trying to shift a business segment. New management trying to shake things up after having great fiscal year 2025.